Design, synthesis and anticancer activity of piperazine hydroxamates and their histone deacetylase (HDAC) inhibitory activity

被引：50

作者：

Chetan, Bhadaliya ^{[1
]}

Bunha, Mahesh ^{[1
]}

Jagrat, Monika ^{[1
]}

Sinha, Barij Nayan ^{[1
]}

Saiko, Philipp ^{[1
]}

Graser, Geraldine ^{[2
]}

Szekeres, Thomas ^{[2
]}

Raman, Ganapathy ^{[3
]}

Rajendran, Praveen ^{[3
]}

Moorthy, Dhatchana ^{[3
]}

Basu, Arijit ^{[1
]}

Jayaprakash, Venkatesan ^{[1
]}

机构：

[1] Birla Inst Technol, Dept Pharmaceut Sci, Ranchi 835215, Jharkhand, India

[2] Gen Hosp Vienna Med Univ Vienna, Dept Med & Chem Lab Diagnost, A-1090 Vienna, Austria

[3] Orchid Res Labs Ltd, Madras 600119, Tamil Nadu, India

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 13期

关键词：

Histone deacetylase inhibitors; Piperazine linker; Hydroxamates; RR pharmacophore; ASSAY; AGENTS; PROLIFERATION;

D O I：

10.1016/j.bmcl.2010.05.020

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Six compounds were synthesized with piperazine in linker region and hydroxamate as Zinc Binding Group ( ZBG). They were screened against three cancer cell-lines (NCIH460; HCT116; U251). Compounds 5c and 5f with GI(50) value of 9.33 +/- 1.3 mu M and 12.03 +/- 4 mu M, respectively, were tested for their inhibitory potential on hHDAC8. Compound 5c had IC(50) of 33.67 mu M. Compounds were also screened for their anticancer activity against HL60 human promyelocytic leukemia cell line due to the presence of pharmacophoric features of RR inhibitors in them. Compound 5c had IC(50) of 0.6 mu M at 48 h. (c) 2010 Elsevier Ltd. All rights reserved.

引用

页码：3906 / 3910

页数：5

共 50 条

[21] Design, synthesis, and antitumor activity evaluation of carbazole derivatives with potent HDAC inhibitory activity
Sun, Likun
Han, Leiqiang
Zhang, Liang
Chen, Chen
Zheng, Chengyun
MEDICINAL CHEMISTRY RESEARCH, 2023, 32 (08) : 1677 - 1689
[22] Design, synthesis, and antitumor activity evaluation of carbazole derivatives with potent HDAC inhibitory activity
Likun Sun
Leiqiang Han
Liang Zhang
Chen Chen
Chengyun Zheng
Medicinal Chemistry Research, 2023, 32 : 1677 - 1689
[23] Acylurea connected straight chain hydroxamates as novel histone deacetylase inhibitors: Synthesis, SAR, and in vivo antitumor activity
Wang, Haishan
Lim, Ze-Yi
Zhou, Yan
Ng, Melvin
Lu, Ting
Lee, Ken
Sangthongpitag, Kanda
Goh, Kee Chuan
Wang, Xukun
Wu, Xiaofeng
Khng, Hwee Hoon
Goh, Siok Kun
Ong, Wai Chung
Bonday, Zahid
Sun, Eric T.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (11) : 3314 - 3321
[24] Synthesis of Sulfonamides and Evaluation of Their Histone Deacetylase (HDAC) Activity (vol 12, pg 1125, 2007)
Oh, Seikwan
Moon, Hyung-In
Son, Il-Hong
Jung, Jae-Chul
Avery, Mitchell A.
MOLECULES, 2009, 14 (05) : 1950 - 1951
[25] Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors
Senger, Johanna
Melesina, Jelena
Marek, Martin
Romier, Christophe
Oehme, Ina
Witt, Olaf
Sippl, Wolfgang
Jung, Manfred
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (04) : 1545 - 1555
[26] Synthesis and anticancer activity of novel histone deacetylase inhibitors that inhibit autophagy and induce apoptosis
Mo, Hualong
Zhang, Ruiqiang
Chen, Yajun
Li, ShuTing
Wang, Yao
Zou, Wenbo
Lin, Qiman
Zhao, Deng-Gao
Du, Yarong
Zhang, Kun
Ma, Yan-Yan
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 243
[27] Enhancing the antitumor activity of ErbB blockade with histone deacetylase (HDAC) inhibition
Chinnaiyan, P
Varambally, S
Tomlins, SA
Ray, S
Huang, SM
Chinnaiyan, AM
Harari, PM
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (04) : 1041 - 1050
[28] Regulation of HDAC1 Histone Deacetylase Activity During Hematopoesis
Yang, Tao
Lou, Yi
Jian, Wei
Bungert, Jorg
Noguchi, Constance Tom
Huang, Suming
Qiu, Yi
BLOOD, 2010, 116 (21) : 1581 - 1582
[29] A structure-activity relationship survey of histone deacetylase (HDAC) inhibitors
Bozorgi, Atefeh Hajiagha
Bagheri, Mehdi
Aslebagh, Roshanak
Rajabi, Mansoureh Sadat
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 2013, 125 : 132 - 138
[30] Anticancer activity of topical ointments with histone deacetylase inhibitor, trichostatin A
Chodkowska, Agnieszka
Bienkowska, Alicja
Slyk, Zaneta
Giebultowicz, Joanna
Malecki, Maciej
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 29 (09): : 1039 - 1049

← 1 2 3 4 5 →